Aptose Biosciences Inc. (15)
Browse by Contract Category
Contracts
-
Employment Agreement dated June 3, 2019 between Aptose Biosciences Inc. and Philippe Ledru
(Filed With SEC on April 11, 2022)
-
Description of Securities
(Filed With SEC on March 22, 2022)
-
Exclusive License Agreement, dated November 4, 2021, by and between Hanmi Pharmaceutical Co. Ltd. and Aptose Biosciences Inc
(Filed With SEC on November 4, 2021)
-
Underwriting Agreement, dated July 15, 2020, between Aptose Biosciences Inc. and Piper Sandler & Co
(Filed With SEC on July 16, 2020)
-
Consulting Agreement dated March 26, 2021 between Aptose Biosciences Inc. and Gregory K. Chow
(Filed With SEC on May 4, 2021)
-
Description of Securities
(Filed With SEC on March 23, 2021)
-
Equity Distribution Agreement, dated May 5, 2020, among Aptose Biosciences Inc., Piper Sandler & Co. and Canaccord Genuity LLC
(Filed With SEC on May 5, 2020)
-
Description of Securities
(Filed With SEC on March 10, 2020)
-
Form of Executive Employment Agreement, dated December 4, 2019, between the Company and Dr. Rafael Bejar
(Filed With SEC on March 10, 2020)
-
Underwriting Agreement, dated December 16, 2019 between Aptose Biosciences Inc. and Piper Jaffray & Co
(Filed With SEC on December 17, 2019)
-
Form of Executive Employment Agreement, dated June 3, 2019, between the Company and Dr. Jotin Marango
(Filed With SEC on August 6, 2019)
-
Underwriting Agreement, dated May 30, 2019 among Aptose Biosciences Inc., RBC Capital Markets, LLC and Canaccord Genuity LLC
(Filed With SEC on May 30, 2019)
-
Equity Distribution Agreement, dated May 24, 2019, among Aptose Biosciences Inc., Piper Jaffray & Co. and Canaccord Genuity LLC
(Filed With SEC on May 24, 2019)
-
Form of Common Share Purchase Agreement dated May 7, 2019 by and between the Company and Aspire Capital Fund, LLC
(Filed With SEC on May 7, 2019)
-
Form of Registration Rights Agreement dated May 7, 2019 by and between the Company and Aspire Capital Fund, LLC
(Filed With SEC on May 7, 2019)